The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands

Genome Research

Volumn 19, Issue 11, 2009, Pages 1974-1982

  Takeshima, Hideyuki ^a   Yamashita, Satoshi ^a   Shimazu, Taichi ^b   Niwa, Tohru ^a   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; RNA POLYMERASE II;

ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE IDENTIFICATION; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER;

CELL LINE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; LYSINE; MALE; METHYLATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROTEIN BINDING; RNA POLYMERASE II; TRANSCRIPTION, GENETIC;

EID: 70350069495     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.093310.109     Document Type: Article

References (51)

1. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837. (Pubitemid 46802390)
2. Boeger H, Bushnell DA, Davis R, Griesenbeck J, Lorch Y, Strattan JS, Westover KD, Kornberg RD. 2005. Structural basis of eukaryotic gene transcription. FEBS Lett 579: 899-903. (Pubitemid 40361862)
3. Boumber YA, Kondo Y, Chen X, Shen L, Guo Y, Tellez C, Estecio MR, Ahmed S, Issa JP. 2008. An Sp1/Sp3 binding polymorphism confers methylation protection. PLoS Genet 4: e1000162. doi: 10.1371/journal.pgen.1000162.
4. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, et al. 2000. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24: 132-138. (Pubitemid 30094712)
5. Dennis G Jr, Sherman BT, Hosack DA, Yang J, GaoW, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: R60. doi: 10.1186/gb-2003-4-9-r60.
6. De Smet C, Loriot A, Boon T. 2004. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 24: 4781-4790. (Pubitemid 38668044)
7. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, et al. 2006. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 38: 1378-1385.
8. Erfurth FE, Popovic R, Grembecka J, Cierpicki T, Theisler C, Xia ZB, Stuart T, Diaz MO, Bushweller JH, Zeleznik-Le NJ. 2008. MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression. Proc Natl Acad Sci 105: 7517-7522. (Pubitemid 351830050)
9. Esteller M, Corn PG, Baylin SB, Herman JG. 2001. A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229. (Pubitemid 32695003)
10. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. 2006. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 38: 540-549.
11. Gal-Yam EN, Jeong S, Tanay A, Egger G, Lee AS, Jones PA. 2006. Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting. PLoS Genet 2: e160. doi: 10.1371/journal.pgen.0020160. (Pubitemid 44504796)
12. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88. (Pubitemid 47031323)
13. Hahn MA, Hahn T, Lee DH, Esworthy RS, Kim BW, Riggs AD, Chu FF, Pfeifer GP. 2008. Methylation of Polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res 68: 10280-10289.
14. Hansen KH, Bracken AP, Pasini D, Dietrich N, Gehani SS, Monrad A, Rappsilber J, Lerdrup M, Helin K. 2008. A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol 10: 1291-1300.
15. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
16. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. 2001. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61: 3573-3577. (Pubitemid 32694963)
17. Jones PA, Baylin SB. 2007. The epigenomics of cancer. Cell 128: 683-692.
18. Keshet I, Schlesinger Y, Farkash S, Rand E, Hecht M, Segal E, Pikarski E, Young RA, Niveleau A, Cedar H, et al. 2006. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 38: 149-153. (Pubitemid 43177227)
19. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R, Farnham PJ. 2004. Silencing of human Polycomb target genes is associated with methylation of histone H3 Lys 27. Genes & Dev 18: 1592-1605. (Pubitemid 38868910)
20. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. 2000. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 32: 970-979. (Pubitemid 30808422)
21. Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-750. (Pubitemid 351748874)
22. Laird PW, Jaenisch R. 1996. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 30: 441-464. (Pubitemid 27015267)
23. Li B, Carey M, Workman JL. 2007. The role of chromatin during transcription. Cell 128: 707-719.
24. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, Tsai YC, Egger G, Gal-Yam EN, Jones PA. 2007. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12: 432-444. (Pubitemid 350046405)
25. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. 2005. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65: 4218-4227. (Pubitemid 40775660)
26. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, et al. 2006. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995. (Pubitemid 43259882)
27. Mihara M, Yoshida Y, Tsukamoto T, Inada K, Nakanishi Y, Yagi Y, Imai K, Sugimura T, Tatematsu M, Ushijima T. 2006. Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins. Am J Pathol 169: 1643-1651. (Pubitemid 351181996)
28. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, Zeitlinger J, Adelman K. 2007. RNA polymerase is poised for activation across the genome. Nat Genet 39: 1507-1511. (Pubitemid 350191341)
29. Nakajima T, Yamashita S, Maekita T, Niwa T, Nakazawa K, Ushijima T. 2009. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int J Cancer 124: 905-910.
30. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242. (Pubitemid 46184356)
31. Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. 2009. The presence of aberrant DNA methylation in non-cancerous esophageal mucosae in association with smoking history: A target for risk diagnosis and prevention of esophageal cancers. Cancer 115: 3412-3426.
32. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, Tomazou EM, Backdahl L, Johnson N, Herberth M, et al. 2008. An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 18: 1518-1529.
33. Robertson KD. 2005. DNA methylation and human disease. Nat Rev Genet 6: 597-610.
34. Rodriguez J, Munoz M, Vives L, Frangou CG, Groudine M, Peinado MA. 2008. Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci 105: 19809-19814.
35. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M. 2003. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63: 3735-3742. (Pubitemid 36793060)
36. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, et al. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-236. (Pubitemid 46184355)
37. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. 2002. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 21: 1048-1061. (Pubitemid 34174517)
38. Suzuki Y, Taira H, Tsunoda T, Mizushima-Sugano J, Sese J, Hata H, Ota T, Isogai T, Tanaka T, Morishita S, et al. 2001. Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites. EMBO Rep 2: 388-393. (Pubitemid 32509953)
39. Ushijima T. 2005. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231. (Pubitemid 40314953)
40. Ushijima T. 2007. Epigenetic field for cancerization. J Biochem Mol Biol 40: 142-150.
41. Ushijima T, Okochi-Takada E. 2005. Aberrant methylations in cancer cells: Where do they come from? Cancer Sci 96: 206-211.
42. Ushijima T, Watanabe N, Okochi E, Kaneda A, Sugimura T, Miyamoto K. 2003. Fidelity of the methylation pattern and its variation in the genome. Genome Res 13: 868-874. (Pubitemid 36621747)
43. Vermeulen M, Mulder KW, Denissov S, Pijnappel WW, van Schaik FM, Varier RA, Baltissen MP, Stunnenberg HG, Mann M, Timmers HT. 2007. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131: 58-69. (Pubitemid 47498531)
44. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874. (Pubitemid 43255707)
45. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, et al. 2008. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903. (Pubitemid 351913645)
46. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I, et al. 2007. Epigenetic stem cell signature in cancer. Nat Genet 39: 157-158. (Pubitemid 46184343)
47. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T. 2006. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-29-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 97: 64-71. (Pubitemid 43257029)
48. Yamashita S, Hosoya K, Gyobu K, Takeshima H, Ushijima T. 2009. Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis. DNA Res (in press)
49. Yates PA, Burman RW, Mummaneni P, Krussel S, Turker MS. 1999. Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation. J Biol Chem 274: 36357-36361. (Pubitemid 30005239)
50. Yuan GC, Liu YJ, Dion MF, Slack MD, Wu LF, Altschuler SJ, Rando OJ. 2005. Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309: 626-630.
51. Zeitlinger J, Stark A, Kellis M, Hong JW, Nechaev S, Adelman K, Levine M, Young RA. 2007. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat Genet 39: 1512-1516. (Pubitemid 350191345)